Ventricular Drainage Sets Market By Type (External Ventricular Drainage Sets, Internal Ventricular Drainage Sets), By Material (Polymer, Silicone), By End-User (Hospitals, Neurosurgery Centers), and By Region; Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Ventricular Drainage Sets Market was valued at USD 0.4 billion in 2024-e and will surpass USD 0.7 billion by 2030; growing at a CAGR of 9.4% during 2025 - 2030.

Ventricular drainage sets are critical tools used in the management of patients with neurological conditions, particularly those with hydrocephalus, intracranial hypertension, or brain injuries. These sets are designed to facilitate the removal of cerebrospinal fluid (CSF) from the ventricles of the brain, reducing pressure and providing relief from the symptoms associated with these conditions. They are typically used in neurosurgery procedures or in emergency care situations to prevent damage to the brain caused by increased pressure.

The global market for ventricular drainage sets is influenced by the rising prevalence of neurological disorders, an aging population, and advancements in medical technology. As healthcare systems continue to improve, the demand for these devices is expected to increase, particularly in hospitals and specialized neurosurgery centers. The increasing recognition of the importance of early diagnosis and treatment of neurological conditions is also contributing to the growth of this market.

External Ventricular Drainage Sets Lead the Market Owing to High Demand in Acute Care

External Ventricular Drainage (EVD) sets dominate the market due to their widespread use in acute care settings. EVD sets are primarily used for patients with elevated intracranial pressure (ICP) and hydrocephalus. These devices are inserted into the ventricles of the brain through a surgical procedure and are used to drain excess CSF, providing immediate relief and preventing further complications. EVDs are commonly employed in emergency rooms, intensive care units (ICUs), and neurosurgical departments.

The demand for external ventricular drainage sets is driven by the increasing number of traumatic brain injuries, hydrocephalus cases, and the need for emergency interventions. EVD sets offer a proven, reliable method for managing increased intracranial pressure, making them the preferred choice in urgent care situations.

Polymer Materials Lead the Market Due to Biocompatibility and Durability

Polymer materials, particularly medical-grade polymers, are the leading material choice for ventricular drainage sets due to their excellent biocompatibility, flexibility, and durability. These materials are commonly used in both external and internal ventricular drainage sets, offering a high level of safety and effectiveness. Polymers are preferred because they can be easily molded into the necessary shapes and are resistant to corrosion, making them ideal for use in medical devices.

The widespread use of polymers in ventricular drainage sets is driven by their ability to meet stringent medical standards and their cost-effectiveness in manufacturing. The development of new polymer materials with enhanced properties, such as greater resistance to wear and tear, is expected to further boost their dominance in the market.

Hospitals Remain the Largest End-User Segment Due to High Demand for Emergency and Critical Care

Hospitals continue to be the largest end-user segment for ventricular drainage sets, driven by their critical role in managing patients with neurological disorders. The high demand for emergency and critical care services, particularly in neurosurgery and intensive care units, ensures that hospitals remain the largest consumers of these devices. As the number of patients requiring urgent medical attention for conditions like hydrocephalus, traumatic brain injury, and stroke increases, the need for ventricular drainage sets in hospitals will continue to grow.

In addition to acute care, hospitals also use ventricular drainage sets for ongoing treatment and monitoring of patients with chronic neurological conditions. As healthcare systems expand and access to advanced medical care improves, hospitals will remain the primary users of these devices.

North America Leads Due to Advanced Neurosurgical Capabilities and High Demand for Surgical Solutions

North America leads the ventricular drainage sets market due to the presence of advanced neurosurgical capabilities and a high volume of surgeries requiring these devices. The United States and Canada are at the forefront of adopting advanced medical devices, driven by their robust healthcare infrastructure and high demand for neurological procedures such as those for hydrocephalus and traumatic brain injuries. The region's focus on improving patient outcomes in neurosurgery further boosts the demand for ventricular drainage sets.

Additionally, North America's emphasis on research and technological advancements in medical devices has resulted in the development of innovative, minimally invasive drainage systems. The region’s strong healthcare funding and patient care standards ensure a continuous market growth for these devices.

Leading Companies and Competitive Landscape

Key players in the ventricular drainage sets market include Medtronic, Johnson & Johnson, and Integra LifeSciences. These companies offer a range of products that cater to both external and internal ventricular drainage needs. Medtronic, in particular, is a market leader with its wide array of drainage sets designed for both acute and long-term care. Johnson & Johnson, through its Ethicon division, also plays a significant role in the market, offering high-quality, reliable drainage sets for use in hospitals and surgical centers. Integra LifeSciences is another prominent player that focuses on advanced neurosurgical products, including drainage sets used in critical care.

As the market continues to grow, competition is intensifying, with companies focusing on improving the design and materials of their products to enhance patient comfort and treatment outcomes. Technological advancements, such as the development of more biocompatible materials and advanced drainage systems, are expected to drive innovation in the market.

Recent Developments:

• In January 2025, Medtronic launched a new external ventricular drainage system featuring enhanced pressure relief and ease of use for neurosurgeons.
• In December 2024, Johnson & Johnson expanded its range of silicone-based ventricular drainage sets to meet the growing demand for flexible and safer options in neurosurgery.
• In November 2024, B. Braun Melsungen AG received regulatory approval for a new range of internal ventricular drainage sets designed for high-precision cerebrospinal fluid management.
• In October 2024, Stryker Corporation introduced an innovative drainage set with improved anti-infection properties, reducing the risk of complications during surgeries.
• In September 2024, Teleflex Incorporated expanded its product portfolio to include advanced ventricular drainage systems with enhanced patient monitoring capabilities.

List of Leading Companies:

• Medtronic plc
• Johnson & Johnson
• B. Braun Melsungen AG
• Smith & Nephew plc
• Stryker Corporation
• Cook Medical
• ConvaTec Group
• Baxter International Inc.
• Abbott Laboratories
• Teleflex Incorporated
• Integra LifeSciences Corporation
• Halyard Health (now part of Owens & Minor)
• KLS Martin Group
• Integra LifeSciences Corporation
• Ecolab Inc.

Report Scope: